Please save the date for a Conference Co-Sponsored by Yale Cancer Center and Smilow Cancer Hospital on

February 8-9, 2018 at Yale Law School

Keynote Speakers

Conference Speakers

More in Progress

• Peter Bach, MD, MAPP: Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
• Robert Bazell, PhD: Professor (Adjunct) of Molecular, Cellular, and Developmental Biology, Yale University
• Edward Benz, MD: President and CEO Emeritus, Dana-Farber Cancer Institute
• Gideon Blumenthal, MD: Deputy Director (Acting), Office of Hematology Oncology Products, U.S. Food and Drug Administration
• Otis Brawley, MD: Chief Medical Officer, American Cancer Society
• Erik Fatemi: Senior Vice President, Cornerstone Government Affairs
• Howard Forman, MD, MBA: Professor of Radiology and Biomedical Imaging, Public Health (Health Policy) and Professor of Epidemiology (Chronic Diseases), Yale School of Medicine
• Charles Fuchs, MD, MPH: Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
• Levi Garraway, MD, PhD: Senior Vice President, Global Development & Medical Affairs, Eli Lilly; Director, Joint Center for Cancer Precision Medicine
• Abbe Gluck, JD: Professor of Law and Faculty Director, Solomon Center for Health Law and Policy, Yale Law School
• Nancy Goodman, JD, MPP: Executive Director, Kids Against Cancer
• Cary Gross, MD: Professor of Medicine (General Medicine) and Epidemiology (Chronic Diseases), Yale School of Medicine
• Peggy Hamburg, MD: Former Commissioner of the FDA (2009-2015)
• Roy Herbst, MD, PhD: Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology, Yale School of Medicine; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
• Amy Kapczynski, JD: Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School
• Aaron Kesselheim, MD, JD, MPH: Associate Professor of Medicine, Harvard Medical School; Director of the Program on Regulation, Therapeutics and Law at Brigham and Women’s Hospital
• Jorge Lopez, Jr., JD: Executive Vice President and General Counsel, Memorial Sloan Kettering Cancer Center
• Abe Lopman, MBA: Senior Vice President, Operations; Executive Director, Smilow Cancer Hospital at Yale New Haven
• Dayna Bowen Matthew, JD: William L. Matheson and Robert M. Morgenthau Distinguished Professor of Law, University of Virginia School of Law
• Barbara McAneny, MD: Co-Founder and CEO, New Mexico Oncology Hematology Consultants
• Lee Newcomer, MD, MHA: Senior Vice President, Oncology, Genetics and Women’s Health, UnitedHealthcare
• Randall Oyer, MD: Medical Director, Oncology Program, Lancaster General Hospital
• Blase Polite, MD: Associate Professor of Medicine, University of Chicago Medical Center
• Katerina Politi, PhD: Associate Professor, Yale School of Medicine
• Nicholson Price, JD, PhD: Assistant Professor of Law, University of Michigan Law School
• Gregory Raskin, MD: Vice President, Technology Development, Memorial Sloan Kettering Cancer Center
• Jessica Roberts, JD: Associate Professor and Director, Health Law & Policy Institute, University of Houston Law Center
• Joseph Ross, MD, MHS: Associate Professor of Medicine (General Medicine) and Associate Professor of Public Health (Health Policy), Yale School of Medicine
• Eugene Rusyn, JD: Lecturer in Law and Senior Fellow, Solomon Center for Health Law and Policy, Yale Law School
• Charles Sawyers, MD: Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
• Richard Schilsky, MD: Chief Medical Officer, American Society of Clinical Oncology
• Deborah Schrag, MD, MPH: Chief, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
• Jeffrey Schwartz, MBA: Managing Director, Bain Capital Life Sciences
• Ellen Sigal, PhD: Chairperson and Founder, Friends of Cancer Research
• Harold Varmus, MD: Lewis Thomas University Professor of Medicine, Weill Cornell Medical College; Former Director of National Cancer Institute & the National Institutes of Health; and former President & CEO of Memorial Sloan Kettering Cancer Center
• Lindsay Wiley, JD, MPH: Professor of Law and Director, Health Law and Policy Program, American University Washington College of Law

Additional participants from the Yale community expected.

Agenda

For the agenda and conference updates, please check the conference website.

Shuttles to and from the Sterling Law Building and the Yale School of Medicine will be provided throughout the day timed for arrival and departure for each panel presentation.

This event is supported by the Oscar M. Ruebhausen Fund at Yale Law School.